Squarepoint’s Xeris Biopharma Holdings XERS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$3.56M Buy
614,550
+131,718
+27% +$873K 0.01% 1752
2025
Q4
$3.79M Sell
482,832
-196,249
-29% -$1.54M 0.01% 1635
2025
Q3
$5.53M Buy
679,081
+394,514
+139% +$2.62M 0.01% 1404
2025
Q2
$1.33M Buy
284,567
+268,572
+1,679% +$1.23M ﹤0.01% 2413
2025
Q1
$87.8K Sell
15,995
-24,774
-61% -$100K ﹤0.01% 4252
2024
Q4
$138K Buy
40,769
+22,084
+118% +$71K ﹤0.01% 4601
2024
Q3
$53.3K Buy
+18,685
New +$48K ﹤0.01% 3974
2022
Q3
Sell
-11,651
Closed -$18K 3566
2022
Q2
$18K Sell
11,651
-121,799
-91% -$257K ﹤0.01% 2778
2022
Q1
$342K Buy
133,450
+119,567
+861% +$292K ﹤0.01% 2203
2021
Q4
$41K Buy
13,883
+1,288
+10% +$2.78K ﹤0.01% 3049
2021
Q3
$31K Sell
12,595
-20,008
-61% -$58.1K ﹤0.01% 2807
2021
Q2
$133K Buy
+32,603
New +$124K ﹤0.01% 2963
2020
Q3
Sell
-45,809
Closed -$122K 2895
2020
Q2
$122K Buy
45,809
+28,973
+172% +$101K ﹤0.01% 1968
2020
Q1
$33K Buy
+16,836
New +$72.4K ﹤0.01% 1753

Other funds holding XERS